(Q73431989)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Prevention and therapy of fungal infections in bone marrow transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

L R Baden

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1038-1041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764365%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402949

3 November 2019

exact match

0 references

cites work

Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Polymerase Chain Reaction Detection ofAspergillusDNA in Experimental Models of Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402949

7 January 2021